Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PREMIER Biosoft Acquires ProteoIQ

Published: Tuesday, March 12, 2013
Last Updated: Monday, March 11, 2013
Bookmark and Share
Company adds strength to its mass spectrometry product portfolio with the acquisition of ProteoIQ from NuSep, Australia.

PREMIER Biosoft has announced the acquisition of ProteoIQ from NuSep a publicly listed Australia firm. With ProteoIQ, PREMIER Biosoft now offers a broad spectrum of products for mass spectrometry based "Omics" and "Imaging" studies to the research community.

With this acquisition, PREMIER Biosoft enters the attractive proteomics market, after successfully launching best-in-class products for the lipidomics, glycomics and MALDI imaging markets.

ProteoIQ is a software tool for proteomic data analysis that streamlines the process of statistical validation, protein quantification and comparative proteomics on one platform.

It supports validation of the proteins identified by other database search tools such as Mascot, SEQUEST, or X!Tandem.

ProteoIQ incorporates the False Discovery Rate and Protein Probability approaches for statistical validation of identified proteins.

It performs quantitative analysis via spectral counting, precursor intensity, iTRACQ, TMT, SILAC and iCAT workflows.

Users can quickly perform differential analysis of results across biological samples thereby facilitating identification of putative biomarkers.

"For the rapidly growing proteomics market, ProteoIQ is a strategic fit to PREMIER Biosoft's existing mass spec product offering and helps consolidate our position as a leader for providing informatics tools for mass spectrometry," said Arun Apte, CEO, PREMIER Biosoft.

This is the second acquisition for the company, after completing the acquisition of Redasoft in August 2011.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PREMIER Biosoft Announces Collaboration with University of Utah
Formal collaboration to advance metabolomics and lipidomics research.
Friday, August 07, 2015
PREMIER Biosoft Wins CIOReview's "Company of the Year" Award
"Company of the Year" award for the year 2014 in the life science category.
Thursday, February 19, 2015
PREMIER Biosoft Launches SimMet for Analysis of MS Metabolite data
SimMet is a high throughput, intuitive informatics tool for qualitative and quantitative analysis of mass spectrometry metabolite data.
Tuesday, May 27, 2014
PREMIER Biosoft Announce Successful Delivery of OligoArchitect™ Online v4.0 to Sigma-Aldrich
As a part of its contract software development services, PREMIER Biosoft has delivered OligoArchitect™ Online v4.0 to Sigma Life Science.
Thursday, September 05, 2013
PREMIER Biosoft and JEOL Enter Agreement
The co-marketing agreement aims to advance research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.
Thursday, June 06, 2013
Premier Biosoft and MRC-Holland Form Alliance
The alliance will help MLPA® users design custom oligos for genes that do not have kits available.
Monday, October 30, 2006
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!